Allspring Global Investments Holdings LLC Has $48.83 Million Holdings in Agilent Technologies, Inc. (NYSE:A)

Allspring Global Investments Holdings LLC decreased its position in shares of Agilent Technologies, Inc. (NYSE:A) by 0.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 335,607 shares of the medical research company’s stock after selling 842 shares during the quarter. Allspring Global Investments Holdings LLC owned approximately 0.11% of Agilent Technologies worth $48,834,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. LPL Financial LLC raised its stake in shares of Agilent Technologies by 11.5% during the third quarter. LPL Financial LLC now owns 57,954 shares of the medical research company’s stock valued at $6,480,000 after acquiring an additional 5,978 shares during the last quarter. Schonfeld Strategic Advisors LLC acquired a new position in Agilent Technologies during the 3rd quarter worth about $707,000. Advisors Asset Management Inc. grew its position in shares of Agilent Technologies by 7.3% in the 3rd quarter. Advisors Asset Management Inc. now owns 15,358 shares of the medical research company’s stock valued at $1,717,000 after buying an additional 1,042 shares during the last quarter. Ameriprise Financial Inc. grew its position in shares of Agilent Technologies by 144.4% in the 3rd quarter. Ameriprise Financial Inc. now owns 1,993,407 shares of the medical research company’s stock valued at $222,907,000 after buying an additional 1,177,883 shares during the last quarter. Finally, Alps Advisors Inc. increased its stake in shares of Agilent Technologies by 95.1% in the third quarter. Alps Advisors Inc. now owns 12,459 shares of the medical research company’s stock valued at $1,393,000 after buying an additional 6,072 shares during the period.

Agilent Technologies Stock Performance

A opened at $126.13 on Thursday. Agilent Technologies, Inc. has a 1-year low of $96.80 and a 1-year high of $155.35. The company has a market cap of $36.80 billion, a price-to-earnings ratio of 29.80, a PEG ratio of 4.40 and a beta of 1.05. The company’s fifty day moving average price is $139.17 and its two-hundred day moving average price is $138.35. The company has a current ratio of 2.15, a quick ratio of 1.64 and a debt-to-equity ratio of 0.34.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, May 29th. The medical research company reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.19 by $0.03. The company had revenue of $1.57 billion for the quarter, compared to analyst estimates of $1.58 billion. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The firm’s revenue was down 8.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.27 EPS. On average, analysts expect that Agilent Technologies, Inc. will post 5.25 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 24th. Investors of record on Tuesday, July 2nd will be given a $0.236 dividend. This represents a $0.94 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date is Tuesday, July 2nd. Agilent Technologies’s payout ratio is currently 22.22%.

Insider Buying and Selling at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $130.00, for a total transaction of $254,540.00. Following the transaction, the chief executive officer now directly owns 25,185 shares in the company, valued at $3,274,050. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, SVP Dominique Grau sold 15,000 shares of Agilent Technologies stock in a transaction on Monday, June 10th. The stock was sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the sale, the senior vice president now directly owns 49,486 shares in the company, valued at approximately $6,595,494.08. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $130.00, for a total transaction of $254,540.00. Following the transaction, the chief executive officer now owns 25,185 shares of the company’s stock, valued at approximately $3,274,050. The disclosure for this sale can be found here.

Analyst Ratings Changes

A has been the topic of several analyst reports. Barclays reduced their target price on Agilent Technologies from $135.00 to $125.00 and set an “underweight” rating on the stock in a report on Friday, May 31st. TD Cowen decreased their price objective on shares of Agilent Technologies from $163.00 to $153.00 and set a “buy” rating for the company in a research report on Thursday, May 30th. Jefferies Financial Group restated a “hold” rating and issued a $135.00 target price (down previously from $152.00) on shares of Agilent Technologies in a report on Monday, June 3rd. Citigroup decreased their price target on Agilent Technologies from $145.00 to $135.00 and set a “neutral” rating for the company in a report on Thursday, May 30th. Finally, Robert W. Baird dropped their price objective on Agilent Technologies from $147.00 to $136.00 and set an “outperform” rating on the stock in a research note on Thursday, May 30th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $137.13.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.